CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia - Wikidata - wikimedia - TriplyDB

CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia

CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia

http://www.wikidata.org/entity/Q34977414

about

Immune Cells in Cancer Therapy and Drug Delivery Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma Dissection of agonistic and blocking effects of CD200 receptor antibodies New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?Inhibitory receptors as targets for cancer immunotherapy Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors.Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia Cancer as an immune-mediated disease.CXCL8, IL-1β and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients.Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2.Natural killer cell immune escape in acute myeloid leukemia.Treatment failure in patients with HPV 16-induced vulvar intraepithelial neoplasia: understanding different clinical responses to immunotherapy.Current strategies in immunotherapy for acute myeloid leukemia.Immune checkpoint blockade immunotherapy to activate anti-tumour T-cell immunity.Immunological dysregulation in multiple myeloma microenvironment.Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia.Targeting B-cell maturation antigen in multiple myeloma.A Truncated form of CD200 (CD200S) Expressed on Glioma Cells Prolonged Survival in a Rat Glioma Model by Induction of a Dendritic Cell-Like Phenotype in Tumor-Associated Macrophages.Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse.Immunoglobulin superfamily members encoded by viruses and their multiple roles in immune evasion.Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease.NK Cell Exhaustion.Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication.Natural killer cells modulation in hematological malignancies.Expression of CD200 on AML blasts directly suppresses memory T-cell function.Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia.The More, The Better: "Do the Right Thing" For Natural Killer Immunotherapy in Acute Myeloid Leukemia.A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia.Immune checkpoint molecules in acute myeloid leukaemia: managing the double-edged sword.Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients.Prognostic impact of CD200 and CD56 expression in pediatric B-cell acute lymphoblastic leukemia patients.Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders.The application of CAR-T cell therapy in hematological malignancies: advantages and challenges CD200:CD200R-Mediated Regulation of Immunity

P2860

Q26747061-8D86A0E8-6EF5-4FAE-A8DB-37FC4892246C Q26751011-78C7C5B6-5513-40F7-A0DE-0392BAF4F88D Q27001052-033C3799-08C3-4C39-8243-93E61C99137B Q28488034-F225E34F-D961-4B4C-9965-5EB04ED10A5D Q34715598-EF042A72-5203-4EF4-AFCE-419B774818F5 Q35553553-8F8D1E86-675C-4FA1-8750-D1FFECA543BF Q35995373-07AA4C62-DFBF-4BB8-B6C7-FF5A5B0F7C5C Q36557537-A70E9943-67E1-4D3C-9D66-0E94645106D5 Q36651344-382BEE99-F357-44A9-9DC3-B84A5233E723 Q37068312-5F73A71E-7544-4FB9-8FBE-3CC865A27BEF Q37108096-D5D3F26B-EC19-4A2E-92D8-D1EA8078ED29 Q37274157-572EF826-9D5E-44C5-89ED-FA564FBD923D Q37348420-4FC7FDD0-87F1-4621-BBAA-C8ACA5A62EEF Q37996816-E894AE51-33A4-49AE-9240-77185723D6EE Q38036688-E3A880C9-ABEC-4916-B324-10650813D77F Q38068967-3A9F7B01-9EA2-4711-A3D0-53EDA973DCE7 Q38108353-57ABB4F3-6C43-4A76-9EA1-14F73283E092 Q38228353-A0FB1902-74A6-4010-B1F5-DB08CA91D884 Q38485334-9847ABA1-4DAD-4FBD-959A-C10843C1E335 Q38586922-78EA13CE-2840-421E-A26B-449405CDA053 Q38775934-A2BA7056-6695-45AC-BA50-E9A6128BCD97 Q38973867-C1CD124A-A14C-4F0A-9758-EE8BE283707F Q39224323-9DAC1566-D205-436A-A344-7C086190EE78 Q39313794-8642D506-70F5-4C9C-81E3-B96114BD8B65 Q39431541-51742A08-C493-4A77-9BF8-7FBE734A9920 Q41168758-DD49FBFF-1636-4E2D-BC8E-D8604B585F8A Q41982546-3C012C57-C8E1-497F-A8F3-5B2E553413C5 Q42572899-35F47BBF-3EED-4DE0-B3C6-A131646A4407 Q46952293-8436D240-E6B9-47F4-A20A-8A43E17EED29 Q47112002-06A885E0-9757-41EC-895A-F718D8634BF1 Q47637581-CA3ADBC6-0C87-40C3-8451-538945ACE6BC Q48273861-289B60ED-7A06-493C-9B58-4B5B2F44885C Q49830211-8B1963BF-F4CE-4476-88AE-31EF11C50B5A Q49838769-EE9848F4-CDDF-4D06-9E30-EEF74147EC96 Q49964009-AD2D13DA-B796-4146-AFBE-715008F190E8 Q52863070-374B8692-914F-400B-ACE9-BB35F32CC7C8 Q57177485-80C2DAF1-9F02-43BC-9FD6-09EE16ED3A97 Q58692091-15D86BD7-396F-4878-98ED-AFC0A150C248

P2860

CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia

http://www.wikidata.org/entity/Q34977414

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

CD200 expression suppresses na ...... onse in acute myeloid leukemia

@ast

CD200 expression suppresses na ...... onse in acute myeloid leukemia

@en

CD200 expression suppresses na ...... onse in acute myeloid leukemia

@nl

type

label

CD200 expression suppresses na ...... onse in acute myeloid leukemia

@ast

CD200 expression suppresses na ...... onse in acute myeloid leukemia

@en

CD200 expression suppresses na ...... onse in acute myeloid leukemia

@nl

prefLabel

CD200 expression suppresses na ...... onse in acute myeloid leukemia

@ast

CD200 expression suppresses na ...... onse in acute myeloid leukemia

@en

CD200 expression suppresses na ...... onse in acute myeloid leukemia

@nl

P1433

Q34977414-3B182C68-BB55-41BA-B01F-4F5CDD326CD7

P1476

Q34977414-D03091AD-FEB0-4E0E-BB6B-16B7EABCE02C

P2093

Q34977414-134D1516-6DBC-4FFE-BE4C-5B84282216D3

Q34977414-57315783-5E6C-4F11-9162-0AEE5074F043

Q34977414-8899A0A7-2428-46D8-A2E5-54696DBC501D

P2860

Q34977414-001B8D9F-60F9-4C15-828C-9411077D7029

Q34977414-0A06ACFE-44C4-440B-B41D-9702540250CB

Q34977414-0EAB660C-5C88-4299-B7CA-77DEAD3F26E7

Q34977414-31B134F3-0D29-4F69-BF45-605DBF0B9F21

Q34977414-36EC380A-2D7F-48F1-8C45-A695687EC01B

Q34977414-37A8639E-D59A-4015-879B-AB33B121A951

Q34977414-43D920A3-9BDE-4A91-A970-1F9336029385

Q34977414-51549254-2897-4437-AA42-D9DDC006C66C

Q34977414-587F2215-C7A3-4875-A6AC-A2727979564E

Q34977414-6428EA01-F1BE-4DEA-B02A-0BDCF0737655

P2888

Q34977414-17EA002E-3501-4801-BDAB-EA4A3DCC8FAB

P304

Q34977414-FF6131F7-ED93-46FE-BC3F-3C2690E4B1AF

P31

Q34977414-D3FF6D2C-2E08-42A0-915D-39DC3AEA924E

P356

Q34977414-94B1745E-ADFD-4F11-9A90-06A250DA0927

P433

Q34977414-92AB4540-2600-42AA-A83D-3F053B05A52A

P478

Q34977414-2CF50851-2269-43FB-89D6-89B3C0786293

P50

Q34977414-41F68789-D9EF-4362-B133-E061E067CD05

Q34977414-8E91DAC4-B895-453F-9F27-E8836BCFF36C

Q34977414-F59755D9-5FEA-413C-A70F-2D6A6BDF2293

Q34977414-F6B05C00-0669-4B5A-9107-96719E85E5E4

P577

Q34977414-D88951DF-14B6-49DB-B260-519BD511D753

P5875

Q34977414-24DEA189-7656-4CCC-8210-C47A1BFA72CE

P6179

Q34977414-12B349D7-0460-4D95-829A-CA4C7AE5C17E

P698

Q34977414-2EBC00E6-23A6-449C-9A01-814FC405B5A4

P921

Q34977414-2DFCFBA9-2021-4A18-BB1C-774402A999E7

Q34977414-D3BAF774-00AB-499C-99D9-CBF39E5F3264

P932

Q34977414-8C629E5C-23D3-49B4-AF6A-889C1C1B6E9C

P356

P1433

P1476

CD200 expression suppresses na ...... onse in acute myeloid leukemia

@en

P2093

A K Burnett

http://www.w3.org/2001/XMLSchema#string

A Tonks

http://www.w3.org/2001/XMLSchema#string

R L Darley

http://www.w3.org/2001/XMLSchema#string

P2860

Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function

The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression

Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias

Down-regulation of the macrophage lineage through interaction with OX2 (CD200)

Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences.

NK cells and apoptosis.

The biology of human natural killer-cell subsets.

CD200 and membrane protein interactions in the control of myeloid cells.

Human NK cells and their receptors.

Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells.

P2888

P304

792-799

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2011.1

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49791676

http://www.w3.org/2001/XMLSchema#string

P6179

1036674631

http://www.w3.org/2001/XMLSchema#string

P698

21274000

http://www.w3.org/2001/XMLSchema#string

P921

P932

3093357

http://www.w3.org/2001/XMLSchema#string